Most Recent
Bill Papas’ girlfriend Louise Agostino has hit back at Westpac’s lawsuit accusing her of involvement in the Forum Group director’s alleged $294 million fraud, denying all allegations and arguing that the bulk of the bank’s claims against her should be struck out.
Big Six firm Herbert Smith Freehills has appointed a PricewaterhouseCoopers veteran as its first director of global workforce strategy and implementation.
Moray & Agnew is facing a lawsuit by a former client who says the firm breached its duties by making an unauthorised $3.3 million transfer while representing him on an investment in a Melbourne storage facility development.
AMP has admitted two of its units charged customers fees for no service but denied it acted unconscionably in a case brought by the corporate regulator alleging it continued to charge advice fees and life insurance premiums to customers who had died.
Pharmaceutical giant Pfizer has fired off a lawsuit against four drug companies for allegedly infringing one of its patents for biologic Enbrel by selling a biosimilar of the blockbuster arthritis drug in Australia.
The corporate regulator has taken Australian Mines to court after its managing director was allegedly caught lying at an investment conference about the value of an offtake agreement and funding for a project at its cobalt and nickel mine in Queensland.
A former receptionist’s claims of ill mental health after allegedly suffering sexual harassment by Australian cricket players and managers do not “ring true”, Cricket Tasmania has argued as the receptionist fights to bring her case out of time.
Virgin Australia has struck back at a lawsuit by its former chief pilot alleging the airline sacked him for complaining of bullying and harassment by its CEO, saying it terminated the pilot's employment after he was deemed medically unfit for his role.
A class action over the failure of six managed investment schemes for eucalyptus wood in Tasmania has accused KPMG of failing to advise forestry giant Gunns that it had to tell growers about $720 million in financing it sought in 2007.
Bayer has dropped its appeal to a ruling that quashed an extension for its patent covering an oral contraceptive, after the Full Court dealt drug makers a blow in two separate cases on how patent term extensions should be calculated.